SCHEMBL492073

SCHEMBL492073

NC1CC2CCN1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3198076 1.00
SCHEMBL3351081 1.00
Hydrochloric Acid SCHEMBL29131455 0.97
Hydrochloric Acid SCHEMBL2346747 0.97
Hydrochloric Acid SCHEMBL2349412 0.97
Hydrochloric Acid SCHEMBL1090593 0.97
SCHEMBL22732393 0.82
SCHEMBL3207004 0.82
SCHEMBL2148328 0.69
SCHEMBL4279010 0.67 SLC18A3 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117263931-A Method for preparing palonosetron hydrochloride 药源药物化学(上海)有限公司 2023-12-22 CN claimed
CN-117019607-A Method for manufacturing molecular material transducer and array 东南大学 2023-11-10 CN claimed
CN-116969932-A Novel molecular ferroelectric Mort insulator material and preparation method and application thereof 东南大学 2023-10-31 CN claimed
CN-110112289-B Molecular ferroelectric phase change memory 东南大学 2023-06-06 CN claimed
CN-108511597-B Molecular-based piezoelectric material and preparation method and application thereof 东南大学 2022-02-11 CN claimed
CN-107203095-B White alkali-soluble photosensitive composition and preparation method and application thereof 江苏广信感光新材料股份有限公司 2020-08-18 CN claimed
CN-107329368-B Alkali-soluble photosensitive composition, and preparation method and application thereof 江苏广信感光新材料股份有限公司 2020-08-14 CN claimed
CN-110041208-A A kind of three-dimensional molecular base ferroelectric memory device 东南大学 2019-07-23 CN claimed
US-20160122337-A1 2-HETEROARYL CARBOXAMIDES BAYER HEALTHCARE AG (DE) 2016-05-05 US claimed
US-20120258964-A1 2-HETEROARYL CARBOXAMIDES BAYER SCHERING PHARMA AG (DE) 2012-10-11 US claimed
EP-1670314-A2 METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS Sequella, Inc. (US) 2006-06-21 EP claimed
EP-1633348-A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES Elan Pharmaceuticals, Inc. (US) 2006-03-15 EP claimed
WO-2005034857-A2 METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS SEQUELLA, INC. (US) 2005-04-21 WO claimed
WO-2004098589-A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARMACEUTICALS, INC. (US) 2004-11-18 WO claimed
EP-0787135-B1 WATER-SOLUBLE EPIPODOPHYLLOTOXIN DERIVATIVES, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG AND FOR TREATING CANCER PF MEDICAMENT (FR) 2000-05-24 EP claimed
EP-0625979-A1 AZABRICYCLIC COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1994-11-30 EP claimed
WO-1993015073-A1 AZABRICYCLIC COMPOUNDS AS CALCIUM CHANNEL ANTAGONISTS SMITHKLINE BEECHAM PLC (GB) 1993-08-05 WO claimed
EP-0190915-B1 Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides SYNTHELABO (FR) 1992-10-28 EP claimed
US-4870181-A AMIDATION OF 3-AMINOQUINUCLIDINE SALT A. H. ROBINS COMPANY, INCORPORATED (US) 1989-09-26 US claimed
EP-0190915-A2 Process for the preparation of 2-alkoxy-N-(1-azabicyclo[2.2.2]octan-3-yl) aminobenzamides SYNTHELABO (FR) 1986-08-13 EP claimed